Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Date:10/1/2013

n">•ABT450/r +ABT267**

ABT333

12 weeksPEARL III

GT1b, treatment-naïve

(400*)

ABT450/r +ABT267**

ABT333

Ribavirin

12 weeks•  ABT450/r +ABT267**

ABT333

12 weeksPEARL IV

GT1a, treatment-naive

(300*)

ABT450/r +ABT267**

 ABT333

 Ribavirin

12 weeks  ABT450/r +ABT267**

 ABT333

12 weeksTURQUOISE II

GT1, treatment-naïve and treatment-experienced (with compensated cirrhosis)

(300*)

 ABT450/r +ABT267**

 ABT333

 Ribavirin

12 weeks ABT450/r +ABT267**

 ABT333

 Ribavirin

24 weeks*projected study population
**ABT-267 is co-formulated with ABT-450/r

In May of 20
'/>"/>

SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
4. AbbVie Declares Quarterly Dividend
5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
(Date:7/30/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... the t:slim® and t:flex™ Insulin Pumps, today announced ... with Dexcom, Inc. to allow the integration of ... G5 and G6 continuous glucose monitoring ("CGM") systems. ... with Dexcom,s future CGM systems is an important ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
(Date:7/31/2015)... ... 31, 2015 , ... Easter Seals Southern Georgia’s Heels & Wheels Duathlon & Triathlon will be ... be 7:30 AM. The duathlon is a 2 mile run, 13 mile bike ride, and ... a 13 mile bike, and a 3 mile run. Heels & Wheels is sponsored ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... base, with the recent implementation of Microsoft Dynamics GP for a senior living ... Intellitec is now supporting senior living communities in 16 states. This further expansion ...
(Date:7/31/2015)... ... 31, 2015 , ... David Gilpin, M.D., a board certified ... Nashville area sinus sufferers about the benefits of Balloon Sinuplasty. , ... is a good candidate for Balloon Sinuplasty. The questionnaire asks questions about symptoms ...
(Date:7/30/2015)... Tucson, AZ (PRWEB) , ... July 31, 2015 , ... ... getaways may seem impossible or out-of-reach. The questions race through your mind: What happens ... is a storm? You feel overwhelmed and cancel your plans. , But not taking ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce ... or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 ... veteran of helping drug, biologic and device firms reduce manufacturing errors by 50 ...
Breaking Medicine News(10 mins):Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 3Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4
... NORTH DARTMOUTH, Mass., Sept. 10 The Sleep Health ... offering all sleep medicine services at one location. By expanding ... Faunce Corner Road location in North Dartmouth, MA, patients now ... disorders. , , While at Sleep Health ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... at home through the merger of rapid diagnostics and health management, ... during the month of September. , , , ... Russell, Vice President, Finance, will attend the Morgan Stanley Global ...
... , NEW YORK, Sept. 10 Reportlinker.com announces that a ... World Bone Grafts Market , ... , , This report analyzes the US market ... is analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized ...
... LISLE, IL, Sept. 10 /PRNewswire-FirstCall/ - SXC Health Solutions ... , TSX: SXC), a leading provider of technology and ... has renewed a multi-year contract, through to June 30, ... Health Benefits Trust Fund (EUTF) of Hawaii. Under the ...
... , WASHINGTON, Sept. 10 Pharmaceutical Research ... the following statement after President Obama,s address to a joint session ... "We agree with President Obama: every American should have access to ... a smart way, health care reform will benefit patients, the economy ...
... Researchers at UC Santa Barbara have developed a new way ... to a non-harmful laser. Their results are published in a ... the American Chemical Society. "This entirely novel tool will ... with temporal and spatial control over when a gene is ...
Cached Medicine News:Health News:Sleep HealthCenters and Southcoast Hospitals Group Expand Patient Services in North Dartmouth 2Health News:Inverness Medical Innovations Announces September Investor Conference Schedule 2Health News:Reportlinker Adds World Bone Grafts Market Report 2Health News:Reportlinker Adds World Bone Grafts Market Report 3Health News:Reportlinker Adds World Bone Grafts Market Report 4Health News:Reportlinker Adds World Bone Grafts Market Report 5Health News:Reportlinker Adds World Bone Grafts Market Report 6Health News:Reportlinker Adds World Bone Grafts Market Report 7Health News:Reportlinker Adds World Bone Grafts Market Report 8Health News:Reportlinker Adds World Bone Grafts Market Report 9Health News:Reportlinker Adds World Bone Grafts Market Report 10Health News:Reportlinker Adds World Bone Grafts Market Report 11Health News:Reportlinker Adds World Bone Grafts Market Report 12Health News:Reportlinker Adds World Bone Grafts Market Report 13Health News:Reportlinker Adds World Bone Grafts Market Report 14Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 2Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 3Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 4Health News:Comprehensive Health Care Reform Should Be National Priority 2Health News:UCSB researchers develop drug delivery system using nanoparticles and lasers 2
... Continuing a tradition of progressive centrifuge ... CL3 series. The Centra-CL3 and Centra-CL3R (refrigerated) ... todays laboratory., Quality Control Over Sample ... and lock up to 99 protocols and ...
Inquire...
... Rotor has a standard 1.5ml rotor and 6 ... Easy operation (no switches to mess with). Simply ... the plastic tab to open. Starts and stops ... 2000 x g. Only five inches in diameter. ...
Inquire...
Medicine Products: